D-0364-2025 Class II Ongoing

Recalled by Direct Rx — Dawsonville, GA

FDA drug recall D-0364-2025 was initiated by Direct Rx on Jan 31, 2025 and is designated Class II. Reason for recall: Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle The recall status is ongoing. Affected quantity: 477 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 23, 2025
Initiation Date
Jan 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
477 bottles.

Product description

CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.

Reason for recall

Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Distribution pattern

Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID

Code information

Lot 11SE2402, Exp Date: 11/30/2025 Lot 14NO2406, Exp Date: 12/31/2025 Lot 29OC2420, Exp Date: 11/30/2025 Lot 30SE2412, Exp Date: 11/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0364-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0364-2025. Report a data issue: hello@regdatalab.com.